Elanco Animal Health (NYSE:ELAN – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, November 7th. Analysts expect Elanco Animal Health to post earnings of $0.12 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Elanco Animal Health (NYSE:ELAN – Get Free Report) last issued its earnings results on Monday, August 7th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.05 by $0.13. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.04 billion. Elanco Animal Health had a positive return on equity of 6.93% and a negative net margin of 2.24%. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.36 EPS. On average, analysts expect Elanco Animal Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Elanco Animal Health Stock Performance
ELAN opened at $9.61 on Friday. The business has a fifty day simple moving average of $10.61 and a 200 day simple moving average of $10.37. The company has a market capitalization of $4.73 billion, a PE ratio of -48.05, a price-to-earnings-growth ratio of 5.79 and a beta of 1.02. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.84 and a quick ratio of 1.53. Elanco Animal Health has a 1 year low of $7.88 and a 1 year high of $14.69.
Analyst Ratings Changes
Institutional Investors Weigh In On Elanco Animal Health
Institutional investors and hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors boosted its position in shares of Elanco Animal Health by 57.0% during the 1st quarter. Captrust Financial Advisors now owns 2,690 shares of the company’s stock valued at $70,000 after purchasing an additional 977 shares in the last quarter. Covestor Ltd boosted its holdings in Elanco Animal Health by 1,285.1% in the first quarter. Covestor Ltd now owns 2,978 shares of the company’s stock worth $78,000 after acquiring an additional 2,763 shares in the last quarter. Advisory Services Network LLC boosted its holdings in Elanco Animal Health by 104.1% in the first quarter. Advisory Services Network LLC now owns 5,204 shares of the company’s stock worth $49,000 after acquiring an additional 2,654 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in Elanco Animal Health in the fourth quarter worth approximately $70,000. Finally, Pearl River Capital LLC bought a new position in Elanco Animal Health in the first quarter worth approximately $205,000. Institutional investors own 95.29% of the company’s stock.
Elanco Animal Health Company Profile
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.
- Five stocks we like better than Elanco Animal Health
- What Are Growth Stocks and Investing in Them
- MarketBeat Week in Review – 10/30 – 11/3
- How to Invest in Insurance Companies: A Guide
- Shocking uranium play that hedge funds kept hidden
- How to Use Stock Screeners to Find Stocks
- Dependable dividends: Why utility stocks are on fire
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.